Organism 191117 - Cryptolepis sanguinolenta (ASCLEPIADACEAE)

Organisms in NAP refer to specimens, they are not "taxonomical" organisms and they can in some cases even be mixtures of organisms. Empty organisms are used as placeholders as the original dataset entry system used organism as the central part.

Search for all experiments on this taxon

Organism Details

Property	Value
Taxon	7658
Family	ASCLEPIADACEAE
Genus	CRYPTOLEPIS
Species	SANGUINOLENTA
Species authority	(LINDL.) SCHLECHTER
Subspecies
Subspecies authority
Comment
Citation	CIMANGA,K: LI,Y: DE BRUYNE,T: ASPERS,P: COS,P: BAKANA,P: KAMBU,K: TONA,L: PIETERS,L: BERGHE,DV: VLIETINCK,AJ:. (2000). INHIBITORS OF XANTHINE OXIDASE AND SCAVENGERS OF SUPEROXIDE ANIONS FROM CRYPTOLEPIS SANGUINOLENTA (LINDL.) SCHLECHTER (PERIPLOCACEAE).. 6(7)
Geographical area	WESTERN AFRICA
Country	CONGO

Experiments

18 experiments

Experiment	Worktypes	Pharmacology	Organism (specimen)	Compound
674015	VOUCHER SPECIMEN REPORTED FORQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOQUINDOLINE
674016	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHINE OXIDASE INHIBITION	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOQUINDOLINE
674017	PHARMACOLOGY OF COMPOUND - IN VITRO	SUPEROXIDE SCAVENGING ACTIVITY INCREASE	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOQUINDOLINE
674018	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Cryptolepis sanguinolenta (ASCLEPIADACEAE)	QUINDOLINE
674019	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHINE OXIDASE INHIBITION	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	QUINDOLINE
674020	PHARMACOLOGY OF COMPOUND - IN VITRO	SUPEROXIDE SCAVENGING ACTIVITY INCREASE	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	QUINDOLINE
674021	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE,NEO:
674022	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHINE OXIDASE INHIBITION	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE,NEO:
674023	PHARMACOLOGY OF COMPOUND - IN VITRO	SUPEROXIDE SCAVENGING ACTIVITY INCREASE	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE,NEO:
674024	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE
674025	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHINE OXIDASE INHIBITION	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE
674026	PHARMACOLOGY OF COMPOUND - IN VITRO	SUPEROXIDE SCAVENGING ACTIVITY INCREASE	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE
674027	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE,11-HYDROXY:
674028	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHINE OXIDASE INHIBITION	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE,11-HYDROXY:
674029	PHARMACOLOGY OF COMPOUND - IN VITRO	SUPEROXIDE SCAVENGING ACTIVITY INCREASE	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE,11-HYDROXY:
674030	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE,BIS:
674031	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHINE OXIDASE INHIBITION	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE,BIS:
674032	PHARMACOLOGY OF COMPOUND - IN VITRO	SUPEROXIDE SCAVENGING ACTIVITY INCREASE	Cryptolepis sanguinolenta (ASCLEPIADACEAE)	CRYPTOLEPINE,BIS:

Show SPARQL Queries (1)